{"id":"b709c9e1-0cf0-567b-a3df-25043f444499","stable_key":"44737fa3-b335-53f4-a644-b9878d4416ac:creatine-mouse-tumor-supplement","predicate":"enhanced","statement":"Creatine supplementation suppressed tumor growth in the tested mouse models and enhanced the effects of PD-1/PD-L1 checkpoint blockade.","claim_class":"mechanistic","status":"source_derived_draft","evidence_grade":"ungraded","direction":"context_dependent","is_public":true,"mechanism_event_id":"7c6140fa-f557-5496-b3fd-0305cea2cf05","mechanism_event_label":"Creatine helped in these mouse immune experiments; benefit for people with cancer was not established.","subject":{"id":"9f5df558-ed3d-5cda-b5ca-0f90f7aa6a8c","slug":"creatine","display_name":"Creatine","entity_type_key":"small_molecule"},"object":{"id":"c40b7a47-199b-5c90-813a-bec8cf951d40","slug":"antitumor-t-cell-function","display_name":"Antitumor T-cell function in mouse models","entity_type_key":"cellular_process"},"evidence_count":1,"mechanism_event":{"id":"7c6140fa-f557-5496-b3fd-0305cea2cf05","stable_key":"44737fa3-b335-53f4-a644-b9878d4416ac:creatine-mouse-tumor-supplement-event","event_type":"biochemical_relationship","label":"Creatine helped in these mouse immune experiments; benefit for people with cancer was not established.","description":"Creatine supplementation suppressed tumor growth in the tested mouse models and enhanced the effects of PD-1/PD-L1 checkpoint blockade.","status":"provisional","compartment":null,"participants":[{"entity":{"id":"9f5df558-ed3d-5cda-b5ca-0f90f7aa6a8c","slug":"creatine","display_name":"Creatine","entity_type_key":"small_molecule"},"role":"subject","stoichiometry":null,"state_label":"","sequence_order":0,"notes":""},{"entity":{"id":"c40b7a47-199b-5c90-813a-bec8cf951d40","slug":"antitumor-t-cell-function","display_name":"Antitumor T-cell function in mouse models","entity_type_key":"cellular_process"},"role":"target","stoichiometry":null,"state_label":"","sequence_order":1,"notes":""}]},"contexts":[{"dimension":"evidence_span","value_text":"{\"source_cache\": \"artifacts/creatine-research/31628186.abstract.txt\", \"locator\": \"Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"2547f09774244dc13d8bd95950b9b313b7fa625436ab778bb52913a64f2ae458\", \"start_char\": 0, \"end_char\": 1076, \"text_sha256\": \"2547f09774244dc13d8bd95950b9b313b7fa625436ab778bb52913a64f2ae458\"}","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"experimental_model","value_text":"Transporter-deficient T cells, tumor models and supplementation experiments","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"exposure","value_text":"Slc6a8 deletion; creatine administration with or without checkpoint blockade","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"limitations","value_text":"Preclinical tumor immunity; no human cancer efficacy or universal tumor effect is inferred.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"nutrient_topic","value_text":"Creatine research collection; topical membership is not evidence of a direct dietary effect.","comparator":null,"unit":null,"notes":"","entity":{"slug":"creatine","display_name":"Creatine","entity_type_key":"small_molecule"}},{"dimension":"organism","value_text":"Mice","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"plain_language","value_text":"Creatine helped in these mouse immune experiments; benefit for people with cancer was not established.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"primary_references","value_text":"[creatine-p31628186] Creatine uptake regulates CD8 T cell antitumor immunity. (2019). https://pubmed.ncbi.nlm.nih.gov/31628186/ DOI: 10.1084/jem.20182044","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"tissue_or_cell_type","value_text":"CD8 T cells and transplanted tumor models","comparator":null,"unit":null,"notes":"","entity":null}],"evidence":[{"id":"7bd1ee56-539d-586b-b8ae-2c1a2e30380f","evidence_kind":"source_excerpt","locator":"Lines 594-605","start_line":594,"end_line":605,"excerpt":"### creatine-mouse-tumor-supplement\nCreatine supplementation suppressed tumor growth in the tested mouse models and enhanced the effects of PD-1/PD-L1 checkpoint blockade.\nCondition category: normal\nnutrient_topic: Creatine research collection; topical membership is not evidence of a direct dietary effect.\nplain_language: Creatine helped in these mouse immune experiments; benefit for people with cancer was not established.\norganism: Mice\ntissue_or_cell_type: CD8 T cells and transplanted tumor models\nexperimental_model: Transporter-deficient T cells, tumor models and supplementation experiments\nlimitations: Preclinical tumor immunity; no human cancer efficacy or universal tumor effect is inferred.\nexposure: Slc6a8 deletion; creatine administration with or without checkpoint blockade\nevidence_span: {\"source_cache\": \"artifacts/creatine-research/31628186.abstract.txt\", \"locator\": \"Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"2547f09774244dc13d8bd95950b9b313b7fa625436ab778bb52913a64f2ae458\", \"start_char\": 0, \"end_char\": 1076, \"text_sha256\": \"2547f09774244dc13d8bd95950b9b313b7fa625436ab778bb52913a64f2ae458\"}\n[creatine-p31628186] Creatine uptake regulates CD8 T cell antitumor immunity. (2019). https://pubmed.ncbi.nlm.nih.gov/31628186/ DOI: 10.1084/jem.20182044","model_system":"Transporter-deficient T cells, tumor models and supplementation experiments","directness":"author_interpretation","verification_status":"source_derived_draft","notes":"Exact curation-document quotation, not publisher quotation. Study references: [creatine-p31628186] Creatine uptake regulates CD8 T cell antitumor immunity. (2019). https://pubmed.ncbi.nlm.nih.gov/31628186/ DOI: 10.1084/jem.20182044","relationship":"supports","weight":1.0,"link_notes":"","source":{"id":"70358046-c5c3-5e9a-9fc9-eb01c3fff88b","stable_key":"import-44737fa3-b335-53f4-a644-b9878d4416ac","title":"Creatine: synthesis, transport, phosphocreatine energetics and nutrient interactions (2026-09-17)","document_type":"imported_text","citation_label":"AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text.","file_path":"","sha256":"548237d3e98a73a7dc02181807921fdd8b902adcee46248792258a761593eda9","revision_id":"88738255-8028-52fb-9c12-0fe92d8ce367","review_status":"unverified_draft","notes":""}}],"relations":[],"conflicts":[],"corrections":[],"research":null}